Damon Bass
0000-0003-2480-5674
1 paper found
Refreshing results…
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea
Missing publications? Search for publications with a matching author name.